GlobeNewswire

Painter 2019: Industry's Most Powerful Digital Paint Software Evolves for Today's Professional Artists

Dela

Latest version offers an all-around more enjoyable user experience thanks to a collection of visual enhancements, performance upgrades, and new brushes that fuel efficiency & creativity

OTTAWA, June 26, 2018 (GLOBE NEWSWIRE) -- Introducing Painter® 2019 - the newest version of the industry's most powerful and creative digital painting software. Designed for professional and aspiring artists on Windows and Mac, Painter 2019 delivers an all-around more enjoyable user experience with a range of enhancements, including stunning visual improvements and modern UI; significant speed and performance boosts; and a collection of all-new brushes to inspire greatness.

"Knowing our users live in Painter every day, we've modernized its look and feel to make the experience of creating art more fluid, streamlined, and enjoyable," said Chris Pierce, Product Manager for Digital Arts at Corel. "These elegant updates make all the difference not only in terms of overall comfort but also to the efficiency of your workflow. If you're a professional artist and your time is money, Painter 2019 is an absolute must-have."

With new and enhanced features, Painter 2019 is the definitive software for artists working in illustration, fine art, gaming, entertainment, comics, manga, photography, and everything in between:

  • NEW! Modern UI for Today's Artists: Painter 2019 introduces a refreshed and professional interface that truly makes your artwork the focus. Main UI elements have been meticulously transformed to reveal an all-new dark theme that allows the interface to melt away so the artwork takes center stage. Continually evolving, Painter now features more than 650 fully redesigned icons that are simple to understand, more efficient to use, and easier on the eyes for artists with high DPI displays.

  • ENHANCED! Performance & Speed Upgrades: Work faster thanks to a number of performance-based enhancements to improve both the brushing experience and working with documents. Artists with AVX2-compatible systems will enjoy up to 38% faster document rendering when zooming, panning, and rotating; as well as brushes that can be up to 75% faster; and an enhanced Brush Ghost that offers a seamless stroke experience with zero lag.
     
  • NEW! Brush Category & More Brushes: Gain inspiration for fresh creations with 36 remarkable new brushes. Discover the all-new Stamps brush category along with a host of additional brushes that round out popular categories such as Selections, Airbrushes, Blenders, Dab Stencils, Glazing, Real Watercolor, Real Wet Oil, Sargent, and Thick Paint. Paint with five new Patterns that are custom designed for concept artists and video game designers, while offering new creative options any artist will love. 

  • NEW & ENHANCED! Color Workflows: Enjoy a more intuitive way to choose and interact with colors using redesigned grabbers in the Color Wheel, Hue Ring, and Saturation/Value Triangle. Users who frequently switch colors can now pin the redesigned Temporal Colors Selector for easy access to any color selection, while greatly reducing the amount of UI in their workspace. And for anyone looking to quickly and easily identify colors that work together, they can now drag the updated color selector over any area of their artwork and instantly discover a color that complements the rest of their masterpiece. 

  • ENHANCED! Multi-Touch, Stylus & Mouse Control: Experience an intuitive way to simultaneously pan, zoom, and smoothly rotate your canvas using two fingers on a Windows touch device, then instantly reset your painting with a simple double-tap. Artists can also quickly zoom in and out of any document with the new Click + Drag feature when using a stylus or mouse. Just click and move to the right to zoom in, or move to the left to zoom out. To zoom into a specific area of interest, just hold the Shift key and drag-click.

Pricing & Availability

Painter 2019 is available in English, French, German, Japanese, and Traditional Chinese for $429 USD / €424.95 / £359.99. Registered owners of any previous version can purchase for the upgrade price of $229 USD / €218.95 / £179.99. UK and European prices include VAT.

Get the free 30-day trial or purchase electronic download versions at www.painterartist.com.

Join the Conversation

Connect with Painter users on Facebook at www.facebook.com/corelpainter, keep up with @CorelPainter on Twitter, discover incredible community artwork on Instagram @CorelPainter, and learn new techniques on the Corel Discovery Center at http://learn.corel.com.

About Corel Digital Arts

Corel is the proud creator of Painter, the world's most realistic paint program. The Painter product family also includes Painter Essentials(TM), the complete entry-level digital art studio, and ParticleShop(TM), a Particle(TM) brush plugin for Photoshop.

Corel is one of the world's top software companies. Our mission is simple: to help people achieve new levels of creativity, productivity, and success.

For more information about the Painter product portfolio, please visit www.painterartist.com.

© 2018 Corel Corporation. All rights reserved. Corel, the Corel logo, the Corel Balloon logo, Painter, Essentials, ParticleShop, and Particle are trademarks or registered trademarks of Corel Corporation and/or its subsidiaries in Canada, the U.S. and elsewhere. All other trademarks mentioned herein are the property of their respective owners. Patents:  www.corel.com/patent .

Alex Brazeau 
PR Manager 
alex.brazeau@corel.com

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/56b4622e-f62c-4763-8821-8c6f79cc4400

http://www.globenewswire.com/NewsRoom/AttachmentNg/85ed2f1d-6e41-4887-b94d-a77ba3e334d8

http://www.globenewswire.com/NewsRoom/AttachmentNg/df3dcdd2-3bd9-4d46-901f-56170f036176

http://www.globenewswire.com/NewsRoom/AttachmentNg/b4a74aa9-ee9b-488e-ac8f-133871029087




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Corel via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum